Zimmer Corporate Integrity Agreement

  • Uncategorized

In a statement from the company, he said the money to be paid was previously recorded in the financial statements. Chad Phipps, senior vice president, general counsel and secretary of Zimmer Biomet, said the company is pleased to have resolved “the old compliance issues at biomet FCPA.” Phipps also said, “Zimmer Biomet is committed to maintaining the highest ethical and legal standards in our business practices worldwide, and we look forward to continuing to integrate Biomet`s existing business activities into our strong corporate compliance program. The investigation began in March 2005, when Zimmer and four other orthopedic companies received subpoenas from the U.S. Department of Justice through the U.S. Attorney`s Office in Newark, New Jersey, seeking information about consulting contracts, professional services contracts, and other agreements by which orthopedic surgeons will receive compensation. Zimmer fully cooperated with federal authorities throughout the investigation and settlement process. Dan is Vice President of Global Compliance at Zimmer Biomet, where he leads the Global Third Party Compliance and Global Operations teams. He joined Zimmer Biomet in 2015 as part of APAC Legal & Compliance. Prior to that, Dan spent five years at an international law firm based in Washington, D.C., where he focused on civil and criminal litigation, regulatory investigations, and corporate compliance issues.

He holds a Bachelor of Arts in Economics and Political Science from the University of Wisconsin-Madison and a Juris Doctor from the University of Chicago School of Law. In June 2016, the Justice Ministry said Biomet had violated the 2012 ODA “due to the behavior in Brazil and Mexico.” After the Justice Department zimmer told Biomet that it was in violation of the 2012 CCA, the company cooperated “unreservedly” and provided information about those involved in the misconduct. This agreement requires Zimmer Biomet to have another three-year DPA with an independent compliance monitor. David Dvorak, President and Chief Executive Officer of Zimmer, said: “We believe this resolution is in the best interests of our shareholders, and we are pleased that the agreement preserves our ability to work with physicians to improve patients` quality of life. It is important to note that solution agreements clearly define how we and our key competitors will interact with healthcare professionals, setting a standard of conduct across the industry. We believe that because of our current enterprise compliance program, which we developed in 2004 and implemented in 2005, Zimmer is well positioned to meet the requirements of comparison. U.S. Attorney Christopher J. Christie acknowledged that Zimmer`s current program already meets many of the compliance requirements contained in agreements with orthopedic companies. Zimmer Biomet first faced FCPA charges from the SEC and, in March 2012, entered into a Deferred Prosecution Agreement (DPA) with the Department of Justice in which it agreed to pay more than $22 million to settle both cases. As part of the SEC settlement, the company agreed to hire an independent compliance consultant to review its FCPA compliance program. Biomet entered into a deferred prosecution agreement (DPA) with the Department of Justice that required it to retain an independent compliance monitor for three years and settled claims with the SEC through an internal administrative order, ceasing the need to go to court.

Benji joined ZB in February 2014. Previously, he worked in private practice, focusing on white-collar crime defense, government investigations, and corporate compliance issues. Benji received his Bachelor of Arts from Princeton University and his Doctor of Laws from Columbia Law School. WARSAW, Indiana, Sept. 27, 2007 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today that it has completed an ongoing federal investigation with the U.S. Attorney`s Office in New Jersey into its financial relationships with consulting orthopedic surgeons. Under the terms of the settlement, Zimmer has entered into a deferred lawsuit agreement, pays a civil settlement amount of $169.5 million, and is subject to the oversight of a federal comptroller appointed by the U.S. Department of Justice for 18 months. Zimmer did not admit to any wrongdoing, pleaded not guilty, and paid no fines under the settlement. In addition, the government has agreed not to lay criminal charges against the company if it complies with the deferred prosecution agreement.

As part of the federal regulation, the company also enters into a five-year business integrity agreement with the Office of the Inspector General of the Department of Health and Social Services. Zimmer understands that the other four orthopaedic companies involved in this case have also entered into settlement agreements. The Company expects to record $169.5 million in settlement expenses in the third quarter. Visit the world wide web rooms in www.zimmer.com Deputy Attorney General Leslie R. Caldwell said, “Under reasonable circumstances, the department will resolve serious criminal behavior in other ways, but there will be consequences for companies that refuse to take these deals seriously.” A copy of zimmer`s deferred prosecution agreement and an overview of Zimmer`s corporate compliance program were posted on the company`s website, www.zimmer.com. Zimmer Biomet entered into a three-year DPA as part of a replacement criminal investigation filed in the District of Columbia in January 2017, accusing the company of failing to implement a system of effective internal accounting controls. In addition to the criminal sanction, Zimmer Biomet has agreed to maintain an independent corporate compliance monitor for three years. .